Technical briefing 10 7 May 2021 This briefing provides an update on previous briefings up to 1 April 2021 Summary •There are 5 variants of concern and 8 variants under investigation (Table 1). VUI-21APR-02 (B.1.617.2) was escalated to a variant of concern on 6 May 2021 (VOC21APR-02). It is assessed as having at least equivalent […]
Category Archives: COVID19
The world is in midst of the COVID-19 pandemic. Recently a new SARS-CoV-2 (2019nCOV)lineage (B.1.526) emerged in New York and spread rapidly. The New York variant B.1.526 lineage is characterised by six lineage-defining mutations in the spike protein, including D614G mutation and one at important residues in the receptor-binding domain (S477N or E484K)1.The combination of […]
The world is in midst of the COVID-19 pandemic. Recently A new “double mutant” variant of the coronavirus has been detected from samples collected in India. The two mutations (E484Q and L452R mutations) come together in the same virus, may be more infectious or less affected by vaccines.1 GeneMedi pseudotype virus (pseudovirus) of SARS-COV-2 (2019nCOV) […]
Technical briefing 16 18 June 2021 This briefing provides an update on previous briefings up to 11 June 2021 Summary There are 4 current variants of concern and 8 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of Delta (VOC21APR-02, B.1.617.2). A separate report is published covering […]
Technical briefing 15 11 June 2021 This briefing provides an update on previous briefings up to 3 June 2021 Summary There are 4 variants of concern and 8 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of Delta (VOC21APR-02, B.1.617.2). A separate report is published covering our […]
